Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children’s Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials

A novel ATXN1-DUX4 fusion expands the spectrum of ‘CIC-rearranged sarcoma’ of the CNS to include non-CIC alterations

(2021) Drew Pratt et al.   ACTA NEUROPATHOLOGICA

Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials

(2021) Santhosh A. Upadhyaya et al.   CLINICAL CANCER RESEARCH

Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors

(2021) Philipp Sievers et al.   ACTA NEUROPATHOLOGICA

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

(2021) David N Louis et al.   NEURO-ONCOLOGY

Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study

(2021) Katja von Hoff et al.   NEURO-ONCOLOGY

Genomes for Kids: The scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing

(2021) Scott Newman et al.   Cancer Discovery

Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study

(2021) Sara Khan et al.   Lancet Child & Adolescent Health

ETMR: a tumor entity in its infancy

(2020) Sander Lambo et al.   ACTA NEUROPATHOLOGICA

Fusions involving BCOR and CREBBP are rare events in infiltrating glioma

(2020) David J. Pisapia et al.   Acta Neuropathologica Communications

EZHIP / CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma

(2019) Jens-Martin Hübner et al.   NEURO-ONCOLOGY

Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features

(2019) Matthew Torre et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial

(2019) Santhosh A Upadhyaya et al.   NEURO-ONCOLOGY

Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials

(2019) Anthony P. Y. Liu et al.   ACTA NEUROPATHOLOGICA

The molecular landscape of ETMR at diagnosis and relapse

(2019) Sander Lambo et al.   NATURE

Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas

(2018) Kristian W. Pajtler et al.   ACTA NEUROPATHOLOGICA

Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations

(2018) Christian Koelsche et al.   ACTA NEUROPATHOLOGICA

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial

(2018) Giles W Robinson et al.   LANCET ONCOLOGY

DNA methylation-based classification of central nervous system tumours

(2018) David Capper et al.   NATURE

Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children’s Oncology Group Randomized ACNS0332 Trial

(2018) Eugene I. Hwang et al.   JOURNAL OF CLINICAL ONCOLOGY

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

(2016) Dominik Sturm et al.   CELL

Exploring genomic alteration in pediatric cancer using ProteinPaint

(2016) Xin Zhou et al.   NATURE GENETICS

Germline Mutations in Predisposition Genes in Pediatric Cancer

(2015) Jinghui Zhang et al.   NEW ENGLAND JOURNAL OF MEDICINE